Advanced Search
Contact | Corporate | Help

Chemotherapy, Radiation Therapy and Immunotherapy Prior to Surgery in Operable Esophageal Cancer

Sponsors:
  • Sarah Cannon Research Institute
  • Genentech
Phases:
  • Phase II
IndicationsAcronym:
  • Esophageal Cancer
Age Groups:
  • Adult
  • Senior
Gender:
Both
Names:
  • Drug: Erlotinib
  • Drug: Bevacizumab
  • Drug: Paclitaxel
  • Drug: Carboplatin
  • Drug: 5-FU
  • Procedure: Radiation therapy
  • Procedure: Surgery
Enrollment:
61

Additional information about NCT00393068.


SourceSolution © 2008-2012